Food Or Edible As Carrier For Pharmaceutical Patents (Class 424/439)
  • Patent number: 11364217
    Abstract: A composition useful for promoting a desired oral microbiota to treat an allergy related respiratory condition in a subject in need of such treatment, the composition including an amino acid containing ingredient including individual molecules of L-arginine; the composition in a configuration to be maintained within the oral cavity for a period of at least about 30 seconds to about an hour, the desired oral microbiota including Veillonella and Streptococcus.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: June 21, 2022
    Assignee: Knoze Jr. Corporation
    Inventor: Shunsheng Han
  • Patent number: 11364478
    Abstract: A method of encapsulating content with calcium alginate membrane to form a capsule. The method includes embedding sodium alginate into a traditional gelatin ribbon used in gelatin encapsulation, adding calcium to a fill material, encapsulating the fill material, and then denaturing the gelatin in the shell. An exemplary use of this method is to form throwable paintballs; however, other products could be formed using this process. A paintball formed by this process is also disclosed.
    Type: Grant
    Filed: May 15, 2020
    Date of Patent: June 21, 2022
    Assignee: Mezzimatic, LLC
    Inventor: Briana Gardell
  • Patent number: 11364255
    Abstract: Compositions including herbal extracts, such as a Vitex negundo extract, a Cardiospermum halicacabum extract, and a Bambusa arundinacea extract, and methods using such compositions are disclosed. For example, compositions and methods may be used to improve joint health.
    Type: Grant
    Filed: July 1, 2020
    Date of Patent: June 21, 2022
    Assignee: KARALLIEF, INC.
    Inventor: Krishna Rajendran
  • Patent number: 11367526
    Abstract: Medical devices and related augmented reality systems and methods are provided. A method of providing guidance to a patient using an electronic device having an imaging device associated therewith involves analyzing one or more images captured by the imaging device to identify image content indicative of a potential activity for the patient, determining, by a control system associated with the electronic device, one or more attributes for the potential activity, determining, by the control system, a predicted physiological response by the patient to the potential activity based at least in part on the one or more attributes, and providing, on a display associated with the electronic device, an augmented reality graphical user interface including a graphical indication influenced by the predicted physiological response.
    Type: Grant
    Filed: May 3, 2019
    Date of Patent: June 21, 2022
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Chia-Hung Chiu, Rebecca K. Gottlieb, Carol A. Jerome, Kenny J. Long
  • Patent number: 11357247
    Abstract: An eggless mayo is provided that is heat stable or that is heat stable as well as freeze-thaw stable and that is all natural. In addition a mayonnaise composition is provided that has increased heat stability as well as freeze-thaw stability. A low-salt version of the eggless mayo is provided as well as compositions for various butters and creams that have enhanced heat stability as well as freeze-thaw stability.
    Type: Grant
    Filed: March 3, 2016
    Date of Patent: June 14, 2022
    Assignee: Texas Tech University System
    Inventor: Richard S. Meyer
  • Patent number: 11337450
    Abstract: UHT treated liquid nutritional compositions are provided having a high caloric content of around 2.0 kcal/ml and higher, a savoury taste and comprising protein, carbohydrate and fat components. The nutritional compositions are for use in the treatment of patients having high energy needs.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: May 24, 2022
    Assignee: FRESENIUS KABI DEUTSCHLAND GMBH
    Inventors: Susanne Wiegand, Katy Becker, Martin Ammann, Jose Maria Mainou-Sierra
  • Patent number: 11331329
    Abstract: The invention provides compositions and methods for utilizing oligosaccharides, such as isolated human milk oligosaccharides, to attenuate a respiratory pathogen infection and/or to promote recovery from a respiratory pathogen infection in the respiratory system and/or the GI tract of a subject.
    Type: Grant
    Filed: May 13, 2021
    Date of Patent: May 17, 2022
    Assignee: Glycosyn LLC
    Inventors: Ardythe L. Morrow, David S. Newburg, John M. McCoy
  • Patent number: 11318171
    Abstract: Methods and egg yolk powder containing compositions for improving skeletal muscle protein fractional synthetic rate (FSR) in mammals and inhibiting or reversing sarcopenia are provided.
    Type: Grant
    Filed: May 18, 2020
    Date of Patent: May 3, 2022
    Assignee: MYOS CORP.
    Inventors: Joseph Mannello, Neerav D. Padliya, Maghsoud Dariani
  • Patent number: 11298332
    Abstract: This disclosure provides a dry powder formulation of free amino acids with an acceptable and even good taste profile.
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: April 12, 2022
    Assignee: AXCELLA HEALTH INC.
    Inventors: Thomas Hanlon, Andrew M. Wood
  • Patent number: 11291628
    Abstract: A chewable pharmaceutical product comprises a matrix comprising: a binder, a bulking agent, a lubricant, a humectant, an emulsifier, and optionally a flavoring, wherein the binder comprises one or more maltitol syrups, which are present in the pharmaceutical product in an amount in the range of 60-70% by weight; and colesevelam hydrochloride.
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: April 5, 2022
    Assignee: Cosette Pharmaceuticals, Inc.
    Inventor: Tommy L. Chau
  • Patent number: 11291683
    Abstract: Compositions for oral administration and processes of preparing the same are described. In particular, compositions in the form of bilayer tablets including B vitamins for modified delivery are described. The bilayer multi-B vitamin tablets offer immediate release of a first set of B vitamins, such as riboflavin (B2) and cyanocobalamin (B12) followed by controlled release of a second set of B vitamins, such as folic acid, biotin, niacinamide (B3), pyridoxine (B6), pantothenic acid (B5) and thiamine (B1).
    Type: Grant
    Filed: March 28, 2017
    Date of Patent: April 5, 2022
    Assignee: ACCESS BUSINESS GROUP INTERNATIONAL LLC
    Inventors: David S. Chang, Dawna Venzon, Shilpa Raut, Allí Klosner, Janjira Intra, Edward S. Kahler
  • Patent number: 11285101
    Abstract: A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: March 29, 2022
    Assignee: Intervet Inc.
    Inventors: Susi Alteheld, Stefan Fuchs, Carina Hang, Jürgen Lutz
  • Patent number: 11278566
    Abstract: The present invention relates to an agent comprising anion-exchange groups that are suitable for adsorbing bacterial lipopolysaccharides (LPS) and/or lipoteichoic acids (LTA), for use in the prevention and/or treatment of inflammatory conditions and/or diseases of the oral cavity or in the vaginal region. The present invention also relates to a pharmaceutical composition that comprises an agent of this kind and can adhere to mucosa.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: March 22, 2022
    Inventor: Dietrich Seidel
  • Patent number: 11266701
    Abstract: The present invention provides a therapeutic composition comprising a synergistic combination of caffeine, Ginkgo biloba, and ?-phenylethylamine (PEA) or its salt. The invention is also directed to oral dosage forms containing said composition, and to a method of treatment of a psychological, psychiatric, behavioral and/or neurodevelopmental disorder comprising the administration of said compositions and dosage forms to a patient in need thereof.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: March 8, 2022
    Assignee: TRINUTRA LTD.
    Inventors: Itschak Lamensdorf, Yoram Sela, Mor Zeilkha
  • Patent number: 11246829
    Abstract: Residence structures, systems, and related methods are generally provided. Certain embodiments comprise administering (e.g., orally) a residence structure to a subject (e.g., a patient) such that the residence structure is retained at a location internal to the subject for a particular amount of time (e.g., at least about 24 hours) before being released. The residence structure may be, in some cases, a gastric residence structure. In some embodiments, the structures and systems described herein comprise one or more materials configured for high levels of active substances (e.g., a therapeutic agent) loading, high active substance and/or structure stability in acidic environments, mechanical flexibility and strength in an internal orifice (e.g., gastric cavity), easy passage through the GI tract until delivery to at a desired internal orifice (e.g., gastric cavity), and/or rapid dissolution/degradation in a physiological environment (e.g., intestinal environment) and/or in response to a chemical stimulant (e.
    Type: Grant
    Filed: June 11, 2020
    Date of Patent: February 15, 2022
    Assignees: Massachusetts Institute of Technology, The Brigham and Women's Hospital, Inc.
    Inventors: Andrew Bellinger, Shiyi Zhang, Carlo Giovanni Traverso, Robert S. Langer, Stacy Mo, Tyler Grant, Mousa Jafari, Dean Liang Glettig, Angela DiCiccio, Lowell L. Wood, Jr., Philip A. Eckhoff
  • Patent number: 11246853
    Abstract: Disclosed is a method for evaluating the ability of a chemical substance or a chemical composition to prevent muscle fatigue and damage induced by physical exertion in humans; edible composition including at least one salt of a multivalent metal cation, at least one compound selected between vitamin E or vitamin E acetate, at least one edible polyphenol compound selected from compounds of the flavonol family, compounds of the anthocyanin family, compounds of the phenolic acid family and compounds of the flavonol family and/or the glucosylated derivatives thereof, in which the molar ratio/is of at least 0.50 and not more than 2.00; its use as a food supplement or for preparing a food supplement composition or as a drug for preventing muscle fatigue and/or muscle damage induced by physical exertion, in a method for the treatment of the human body by therapy.
    Type: Grant
    Filed: March 8, 2017
    Date of Patent: February 15, 2022
    Assignee: SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC
    Inventors: Laetitia Cattuzzato, Catherine Kern, Ambre De Pooter
  • Patent number: 11234930
    Abstract: Coconut oil, coconut oil blends that are high in MCTs such as LouAna® liquid coconut oil, pure MCT oils, Omega-3 oils, cannabidiol (CBD), hemp extract, tree nut oil, macadamia oil, almond oil, cashew oil, avocado oil, docosahexaenoic acid (DHA), fish oil, and/or conjugated linoleic acid (CLA) may be emulsified to create an emulsified oil or blend that may take the form of a creamy shot or a cream substitute. These oils and/or blends may be emulsified using an emulsifier that may be selected from the following: sunflower lecithin, sodium stearoyl lactylate (SSL), acacia gum, beta-cyclodextrin, and combinations of same. By emulsifying these oils/oil blends, a good tasting creamy shot or a cream substitute can be formed.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: February 1, 2022
    Inventor: Jesse Windrix
  • Patent number: 11234897
    Abstract: Multi-dose packaged over-the-counter antitussive syrups comprise a bottle containing about 75 ml or less of a liquid formulation of dextromethorphan hydrobromide. The liquid formulation provides at least two doses of dextromethorphan hydrobromide. Multi-dose packaged over-the-counter liquid formulations comprise a bottle having a capacity of about 100 ml or less, at least two doses of the liquid formulation carried within the bottle, a cap, a dosage cup releasably carried on the cap and a shrink wrap substantially enveloping the bottle and the dosage cup. Antitussive syrups comprise water, dextromethorphan hydrobromide in amounts from about 6 to about 25 mg/ml, and sweetener in amounts from about 200 to about 800 mg/ml.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: February 1, 2022
    Assignee: DXM Pharmaceutical, Inc.
    Inventors: Mark Lawrence Thuesen, Steve Shane Sanders, Steve J. Bannister
  • Patent number: 11229605
    Abstract: An example device includes at least one three-dimensional (3D) printed tablet and a 3D-printed production support structure. Each 3D-printed tablet includes an excipient material and an active ingredient. The 3D-printed support structure includes a 3D-printed planar structure comprising the excipient material and at least one 3D-printed connecting member comprising the excipient material. The planar structure includes at least one aperture, each aperture corresponding to one of the at least one 3D-printed tablet. The connecting member detachably connects the at least one 3D-printed tablet with the 3D-printed planar structure and positions the at least one 3D-printed tablets within the apertures.
    Type: Grant
    Filed: February 15, 2017
    Date of Patent: January 25, 2022
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: Wei Huang, Nathan Moroney, Steven J. Simske, Gary J. Dispoto
  • Patent number: 11229703
    Abstract: A method for inducing abscopal, complete or partial response to radiotherapy comprising administering isoflavone compounds and irradiating with a cytotoxic dose of ionising radiation so that fewer than all of the plurality of tumours are irradiated.
    Type: Grant
    Filed: April 6, 2017
    Date of Patent: January 25, 2022
    Assignee: NOXOPHARM LIMITED
    Inventor: Graham Kelly
  • Patent number: 11216768
    Abstract: A product quality analysis and control system is provided. The product quality analysis and control system includes a processing system that is configured to receive data of objective qualities of a product from multiple data gathering modules. Each of the multiple data gathering modules is respectively positioned at corresponding nodes of a supply chain and is configured to receive from sensors data of objective qualities of a product when the product is at each of the corresponding nodes. The processing system includes a model repository and a data evaluation module. The data evaluation module is configured to select, from the model repository, a model associated with a type of the product and to use the model to analyze the data to identify changes in the objective qualities along the supply chain.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: January 4, 2022
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Paulo Rodrigo Cavalin, Carmen Nilda Mena Paz, Jaione Tirapu Azpiroz, Ana Paula Appel, Alexandre Alves
  • Patent number: 11197492
    Abstract: An apparatus includes a food product, at least one ingestible device associated with the food product to communicate information and at least one coating material surrounding the at least one ingestible device is disclosed. The ingestible device is associated with an ingestible medication to be ingested in conjunction with the food product. The coating is configured to release the at least one ingestible device upon the occurrence of an event.
    Type: Grant
    Filed: July 17, 2019
    Date of Patent: December 14, 2021
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Lawrence Arne, Mark Zdeblick, Aditya Dua, George Savage, Robert Leichner, Jafar Shenasa, Patricia Johnson, Raymond Schmidt, Zahedeh Hatamkhany, Veeraperumanallu Muralidharan
  • Patent number: 11191750
    Abstract: Disclosed are methods and compositions for the treatment or prevention of intestinal polyps or prevention of cancer in a patient who has been identified as being at risk for developing intestinal polyps or intestinal cancer. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR).
    Type: Grant
    Filed: June 29, 2020
    Date of Patent: December 7, 2021
    Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Zelton Dave Sharp, Randy Strong, Paul Hasty, Carolina Livi, Arlan Richardson
  • Patent number: 11173170
    Abstract: The present invention relates to a prebiotic composition comprising a galacto oligosaccharide (GOS) produced from Lactobacillus plantarum, wherein the GOS acts as a selective growth medium for a chosen Lactobacillus plantarum probiotic bacterial strain, and wherein the GOS is substantially the same as the form produced by reverse ?-galactosidase reaction in the chosen probiotic bacterial strain. The present invention also relates to methods of producing GOS and related composition incorporating the GOS.
    Type: Grant
    Filed: November 5, 2015
    Date of Patent: November 16, 2021
    Assignee: Optibiotix Limited
    Inventors: Stephen Patrick O'Hara, Sofia Kolida
  • Patent number: 11173167
    Abstract: The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.
    Type: Grant
    Filed: June 17, 2020
    Date of Patent: November 16, 2021
    Assignee: Metabolic Technologies, Inc.
    Inventors: John Rathmacher, John Fuller, Jr., Shawn Baier, Steve Nissen, Naji Abumrad
  • Patent number: 11166912
    Abstract: An orally administrable micellar composition is provided. The composition comprises a pharmaceutical agent encapsulated in micelles formed by at least one micelle-forming compound in a pharmaceutically acceptable aqueous solvent comprising an alkali metal salicylate and a pharmaceutically acceptable edetate combined with at least one physiologically acceptable film forming agent.
    Type: Grant
    Filed: March 3, 2016
    Date of Patent: November 9, 2021
    Assignee: CTT Pharma Inc.
    Inventor: Pankaj Modi
  • Patent number: 11166968
    Abstract: The present invention relates to compositions, particularly compositions useful in maintaining and supporting healthy microflora in the female urogenital tract which could lead to inhibition of vaginal infections, as well as methods of treating and preventing vaginal infections. Compositions useful in supporting healthy microflora, disclosed herein, generally comprise a therapeutic amount of a first saccharide and a therapeutic amount of a second saccharide or an organic acid. The saccharides may be, for example, a pentose, a disaccharide, a cyclodextrin, a pectic substance or a non-digestible polysaccharide. The organic acid may be, for example, malic acid.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: November 9, 2021
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: Jingru Li, Lindsay Adrienne Peed, Cheryce Francina Joyner, Rebecca Ann Vongsa, David William Koenig, Ryan Daniel Bartell, Paige Nicole Hollmaier
  • Patent number: 11154499
    Abstract: The disclosure is directed to methods related to creatinine, for example, a method for its safe administration to a human, a method for using creatinine to improve the bioavailability of creatine, and a metn.
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: October 26, 2021
    Assignee: THERMOLIFE INTERNATIONAL, LLC
    Inventors: Alexandros Nikolaidis, Ronald Kramer
  • Patent number: 11147856
    Abstract: The present invention relates to hot flash-suppressing agents and menopausal disorder-improving agents and a food and drink and a pharmaceutical preparation for suppressing hot flash, containing ?-lactalbumin as an active ingredient.
    Type: Grant
    Filed: April 6, 2016
    Date of Patent: October 19, 2021
    Assignee: MEIJI CO., LTD.
    Inventors: Masayuki Uchida, Orie Kobayashi
  • Patent number: 11141447
    Abstract: Composition for treatment and management of addiction and method of preparation thereof are disclosed herein. The disclosed herbal composition includes herb and mineral which facilitate in treating addiction. It may be used to treat addiction such as alcohol addiction, tobacco addiction, excessive smoking, drugs abuse etc. Further, the disclosed composition may also be instrumental in treating complications associated with addiction and withdrawal symptoms.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: October 12, 2021
    Assignee: Muniyal Ayurvedic Research Centre
    Inventor: M Vijayabhanu Shetty
  • Patent number: 11135157
    Abstract: The invention relates to an oral tablet for delivery of active ingredients to the throat comprising a population of particles and an active ingredient to be delivered to the throat, the population of particles comprising directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas, the non-DC areas resulting in induced saliva generation upon mastication of the tablet, wherein the tablet is designed to be masticated and designed to deliver the active ingredient to the throat as part of the saliva generated upon mastication of the tablet.
    Type: Grant
    Filed: May 17, 2018
    Date of Patent: October 5, 2021
    Assignee: FERTIN PHARMA A/S
    Inventor: Helle Wittorff
  • Patent number: 11116731
    Abstract: A method of treating Atrial Fibrillation or a pre-Atrial Fibrillation condition in a mammal, preferably a human, comprising administering a therapeutically effective amount of one of organic or inorganic sulfide, organic or inorganic nitrite, both organic or inorganic sulfide and organic or inorganic nitrite, or pharmacologically acceptable salts, solvates, esters, amides, clathrates, stereoisomers, enantiomers, prodrugs or analogs thereof, or a combination thereof.
    Type: Grant
    Filed: February 20, 2018
    Date of Patent: September 14, 2021
    Assignee: Brd. of Sup. of LSU and A &M College
    Inventors: Christopher G. Kevil, Paari Dominic
  • Patent number: 11110118
    Abstract: The disclosure provides for pharmaceutical compositions comprising an alginate salt, such as sodium alginate. The disclosure further provides for processes and methods for making pharmaceutical compositions. In yet a further aspect, the disclosure provides for methods of utilizing a pharmaceutical composition for treatment of acid reflux diseases. In another aspect, the disclosure provides for formulations suitable for oral use in dosage forms of capsules and dry powders.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: September 7, 2021
    Assignee: PHARAGEN LLC
    Inventor: Joseph Ryan Smolarz
  • Patent number: 11096892
    Abstract: A film forming composition comprises a film forming component and a solvent, wherein the film forming component comprises 0-50 wt % of a first water soluble polymer, 0.3-40 wt % of a second water soluble polymer, 0-15 wt % of plasticizer and 50-70 wt % of active ingredient. The first and second water soluble polymers have a Tg of ?52° C. to 216° C., and difference of Tg values of the first and second water soluble polymer is 62-268° C. The film formed by the film forming composition capable to load high content of active ingredient and lead to fast absorption of active ingredient is provided.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: August 24, 2021
    Assignee: Nano and Advanced Materials Institute Limited
    Inventors: Jinjie Xu, Sau Kuen Connie Kwok, Wah Kit Cheuk, Ying Li, Pak Ho Lau
  • Patent number: 11096890
    Abstract: The present invention provides a chewable dosage form having a matrix comprising: a combination of active pharmaceutical ingredients which is metformin hydrochloride and sitagliptin or a pharmaceutically acceptable salt thereof; a fully or partially pregelatinized starch, a polyethylene glycol polymer; a lubricant; an emulsifier; a flavoring agent; and a sweetener. The present invention also provides a method of treating diabetes, e.g., non-insulin dependent (Type 2) diabetes mellitus, comprising administering a therapeutically effective amount of the chewable dosage form to a mammalian patient in need thereof.
    Type: Grant
    Filed: September 25, 2018
    Date of Patent: August 24, 2021
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Wycliffe S. Omwancha, Rubi Burlage
  • Patent number: 11083760
    Abstract: A formulated oral prebiotic edible composition useful for promoting a desired oral microbiota to treat a respiratory allergic condition and/or an oral and/or sinus infection condition in a subject in need of such treatment, the oral prebiotic including comprising L-arginine, the L-arginine including free individual molecules of L-arginine, the free individual molecules of L-arginine L present at a concentration of greater than about 0.1 wt %; a carrier, and a sugar comprising at least one of a monosaccharide and disaccharide; the composition in a configuration suitable to be maintained including being substantially dissolved within the oral cavity for over a period of at least about 1 minute to about an hour, the composition in an effective amount to thereby selectively promote an increased concentration of oral microbiota to thereby treat the respiratory and/or oral and/or sinus related allergy condition, the selected oral microbiota including Veillonella and Streptococcus.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: August 10, 2021
    Assignee: Knoze Jr. Corporation
    Inventor: Shunsheng Han
  • Patent number: 11040060
    Abstract: Methods for managing the body mass index, the body fat percentage and/or the distribution of fat storage sites of humans are provided, and more particularly the use of food compositions for managing the body mass index, the body fat percentage and/or the distribution of fat storage sites by administering to a human in need of managing body mass index, body fat percentage and/or distribution of fat storage sites an effective amount of a food formulation comprised of an esterified pectin having a degree of esterification (DE) of less than 65%.
    Type: Grant
    Filed: December 2, 2019
    Date of Patent: June 22, 2021
    Assignee: DSM IP ASSETS B.V.
    Inventors: Hendrik Arie Schols, Paulus De Vos, Marco Alexander Van Den Berg, Geert Bruggeman, Erik Martinus Adrianus Maria Bruininx, Neha Mohan Sahasrabudhe, Jan Scholte, Lingmin Tian, Anton Johannes Scheurink
  • Patent number: 11019836
    Abstract: Provided are food products having structures, textures, and other properties similar to those of animal meat, and that comprise substantial amounts of cell wall material. Also provided are methods and processes for producing such food products.
    Type: Grant
    Filed: August 1, 2016
    Date of Patent: June 1, 2021
    Inventors: Timothy Geistlinger, Michael S. Timmons
  • Patent number: 11013714
    Abstract: The present invention primarily relates to the use of Homoeriodictyol (HED) or a salt thereof or a mixture of HED and one or more salts thereof or a mixture of several salts thereof for reducing the gastric acid secretion-stimulating effect of N-Acetyl-4-aminophenol (Paracetamol).
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: May 25, 2021
    Assignee: SYMRISE AG
    Inventors: Joachim Hans, Jakob Peter Ley, Susanne Paetz, Silke Middendorf, Kathrin Liszt, Veronika Somoza
  • Patent number: 11006658
    Abstract: Compositions comprising polysaccharides and oligosaccharides are provided. Methods for the formation of the compositions, including the enzymatic production of the oligosaccharides, and the uses of the compositions in foodstuffs, cosmetics, and nutraceuticals are also provided.
    Type: Grant
    Filed: April 9, 2020
    Date of Patent: May 18, 2021
    Assignee: Cambridge Glycoscience Ltd
    Inventor: Thomas J. Simmons
  • Patent number: 10993466
    Abstract: Methods of preparing a delivery system are described. Each method uses a first and second printing materials. The second printing material contains an active material such as a fragrance, flavor, malodor counteracting agent, and mixture thereof.
    Type: Grant
    Filed: April 25, 2016
    Date of Patent: May 4, 2021
    Assignee: INTERNATIONAL FLAVORS & FRAGRANCES INC.
    Inventors: Lewis Michael Popplewell, Franklin Pringgosusanto, Lulu Henson
  • Patent number: 10980786
    Abstract: The present invention generally relates to the early prevention of overweight, obesity, excessive fat accumulation and/or associated metabolic disorders in infants or children. For example, the present invention relates to the prevention of overweight, obesity, excessive fat accumulation and/or associated metabolic disorders in infants or children through appropriate nutrition for women desiring to get pregnant and/or during pregnancy and/or lactation. Embodiments of the present invention relate to the Vitamin B6 for use in the prevention of overweight, obesity, excessive fat accumulation and/or associated metabolic disorders in the offspring, wherein the vitamin B6 is administered to women desiring to get pregnant and/or to the mother during pregnancy and/or lactation and to maternal food compositions that can be used for this purpose.
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: April 20, 2021
    Assignee: NESTEC S.A.
    Inventors: Cyrus Cooper, Peter David Gluckman, Keith Malcolm Godfrey, Catherine Mace, Irma Silva Zolezzi
  • Patent number: 10967043
    Abstract: This invention provides a method of colonic cleansing.
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: April 6, 2021
    Assignee: Bausch Health Ireland Limited
    Inventors: Dennis Riff, Gary S. Jacob, Kunwar Shailubhai, Patrick H. Griffin
  • Patent number: 10967024
    Abstract: A synergistic herbal stimulant composition comprises a mixture, in powdered or extract form, of two or more herbal stimulant ingredients and at least one catalytic herbal ingredient, which effects a synergy between the herbal stimulant ingredients. The herbal stimulant ingredients are preferably selected from the group consisting of Horny Goat Weed (Epimedium Sagittatum), Rhodiola Root (Rhodiola Rosea), Elueuthero Root (Eleutherococcus), Nettle Leaf (Urticaria Dioica), Ashwagandha Root (Withania Somnifera), Maca Root (Lepidium Meyenii), Moringa Root (Moringa Oleifera), and Cowitch (Macuna Pruriens). The catalytic herbal ingredient is preferably Moses-in-a-basket (Tradescantia Spathacea).
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: April 6, 2021
    Inventor: Aretha Duncan
  • Patent number: 10952461
    Abstract: The invention provides a smokeless tobacco product comprising a tobacco extract. In some embodiments, the smokeless tobacco product is translucent. The invention further provides methods for making and using the smokeless tobacco product. In certain embodiments, the smokeless tobacco product comprises isomalt, maltitol syrup, and a translucent tobacco extract prepared by ultrafiltration.
    Type: Grant
    Filed: January 31, 2018
    Date of Patent: March 23, 2021
    Assignee: R.J. Reynolds Tobacco Company
    Inventor: Darrell Holton, Jr.
  • Patent number: 10940129
    Abstract: The present disclosure relates to the use of lipophilic mercaptans for the treatment of pain sensitization. The lipophilic mercaptans disclosed can be used to decrease the formation of protein-aldehyde adducts within nociceptive nerves, thereby reducing sensitization to pain.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: March 9, 2021
    Inventor: David Michael Ott
  • Patent number: 10918125
    Abstract: Generating an optimised formulation for a foodstuff, comprises receiving at a processor physicochemical data pertaining to one or more plant extracts and operating the processor to calculate a time, Tmax, representing a time to reach a maximum concentration in plasma of at least one metabolite of the one or more plant extracts by applying the received physicochemical data to a mathematical model stored in memory. The processor is then operated to identify ones of the metabolites for which the calculated Tmax substantially corresponds with a target absorption time for the foodstuff; and to generate an optimised formulation for the foodstuff comprising the one or more plant extracts containing the identified metabolites. The physicochemical data include one or more of molecular mass (M), liphophilicity (log P) and Polar Surface Area (PSA).
    Type: Grant
    Filed: August 3, 2015
    Date of Patent: February 16, 2021
    Assignees: Commonwealth Scientific and Industrial Research Organisation, Horticulture Innovation Australia Limited
    Inventors: Rosalind B. Miller, Louise Elizabeth Bennett, Sophie Ngoc Bich Selby-Pham
  • Patent number: 10912295
    Abstract: The present invention relates to an agrochemical combination of (i) linolenic acid, a linolenic acid derivative, a linolenic acid breakdown component, or an ester thereof; and (ii) inositol, an inositol derivative or an inositol breakdown component. The invention also relates to agrochemical compositions comprising the same and the use such a combination for improving plant physiology.
    Type: Grant
    Filed: March 12, 2018
    Date of Patent: February 9, 2021
    Assignee: Crop Intellect Ltd.
    Inventor: Apostolos Papadopoulos
  • Patent number: 10900058
    Abstract: Methods are disclosed for the enzymatic preparation of galactooligosaccharide (GOS) from lactose using two different microbial lactase enzymes to maximize the extent of transgalactosylation during the digestion of lactose. Methods are also disclosed for avoiding the turbidity of a solution comprising GOS and lactose as it is adjusted for incubation with a yeast neutral lactase.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: January 26, 2021
    Assignee: VITALUS NUTRITION INC.
    Inventor: Stephen Tomiuk
  • Patent number: RE48607
    Abstract: Disclosed are thickener compositions composed of xanthan gum and a chelating agent, such as ascorbic acid. The chelating agent is present in an amount with respect to said xanthan such that, when said thickener composition is used to thicken a food product, at least one mineral selected from the group consisting of iron, zinc, and calcium present in said food product is relatively more bioavailable than the mineral would be in the absence of said chelating agent. The thickener composition finds particular applicability for use with baby formulas and breast milk intended for dysphagic infants. Also disclosed are baby formulas and thickened breast milk formulations, methods for preparing same, and methods for providing nutrition.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: June 29, 2021
    Assignee: Kent Precision Foods Group, Inc.
    Inventor: Douglas A. Stetzer